Neoadjuvant treatment in 2025 Advance your expertise in neoadjuvant therapy and melanoma care at our upcoming symposium for multidisciplinary specialists.

Join me & MIA multidisciplinary experts at Neoadjuvant Treatment Symposium, to help clinicians navigate the evolving treatment landscape for #melanoma, after recent PBS listing for #neoadjuvant regimens. Mon evening 24 Nov AEDT in person in Sydney, or online. events.humanitix.com/neoadjuvant-...

INNOVATE Naples - Paolo Ascierto hosts clinician/researchers discussing #CANCER #NEOADJUVANT #immunotherapy. Favorite meeting for patient-centered novel trials. Discussed optimising immunotherapy across multiple cancers & #melanoma to cure more Grazie tutti!

Important week - #UnitedNation international #women’s day week! Honoured to speak about courage, unconscious bias, inspiration, and my 5 best pieces advice 4 action & change. #ING #marieclaire #NSWeducation #RoyalSocietyNSW @sydneyuni.bsky.social @melanomaau.bsky.social

Neoadjuvant triplet immune checkpoint blockade in newly diagnosed glioblastoma - Nature Medicine A patient with newly diagnosed glioblastoma was safely treated with neoadjuvant nivolumab, relatlimab and ipilimumab before maximal resection, with comprehensive immune profiling showing the induction...

This #science exciting! Collaborate, #clincaltrials, nurses, scientists - my co-lead H Rizos🤩. #immunotherapy 4 #GBM #glioblastoma Handed draft trial design+drugs to @jimwhittle.bsky.social @braincancercentre.bsky.social

@sydneyuni.bsky.social @melanomaau.bsky.social
www.nature.com/articles/s41...

Can this melanoma therapy beat brain cancer? We’re about to find out A world-first clinical trial will investigate whether the experimental treatment given to a former Australian of the Year can treat aggressive tumours in other patients.

www.smh.com.au/national/can...
@sydneyuni.bsky.social @wehi-research.bsky.social @jimwhittle.bsky.social @braincancercentre.bsky.social @melanomaau.bsky.social @science.org.au @ascocancer.bsky.social @ascopost.bsky.social @sitcancer.bsky.social

Ipilimumab plus nivolumab versus nivolumab alone in patients with melanoma brain metastases (ABC): 7-year follow-up of a multicentre, open-label, randomised, phase 2 study Our findings suggest that ipilimumab plus nivolumab maintains efficacy to at least 7 years in patients with active asymptomatic brain metastasis. Upfront ipilimumab plus nivolumab should be the standa...

So proud of this aussie trial - changed practice. @melanomaau.bsky.social @sydneyuni.bsky.social
@science.org.au
Ipilimumab + nivolumab vs nivolumab in patients with #melanoma brain metastases (ABC): 7-yr follow-up of randomised, ph 2 study - The Lancet Oncology www.thelancet.com/journals/lan...

Welcome ‘25 @melanomaau.bsky.social fellows. Ciao fab Drs fr 2024 Ruby, Bec & Andea, work with top #clinicaltrials team & advance practice #nurses. Togeth we deliver #cancer care, keep patients SAFE & push boundaries - 0 deaths fr #melanoma. ❤️ Working to make a difference-Highlight of my work week.

Australian of the Year 2025

Governor General of Australia, Sam Mostyn and Australian of the Year Alumni and Australian of the Year 2025 nominees

Prime Minister Anthony Albanese (second from right) and my Mum Ann Long, Richard Harris and Me - Georgina Long

Australian War Memorial

Celebrating #australianoftheyear 2025 with my kids (1 in USA), my rock of a husband&my wise Mum. Lost Dad in 2024 ❤️ but made pioneering #melanoma research & transformed clinical practice, groundbreaking science with brilliant women, exploring Australia & #changemakers.

youtu.be/VfJKuE114Do?...

What an amazing group of 2025 Australians of the Year! Tears flowed freely as their stories were told - Neale #fightnmd, Olly #wheelchairs for kids, Katrina #QUT and Vanessa & Hannah #cafesteppingstone. Making #Australia a better place! @sydneyuni.bsky.social @melanomaau.bsky.social #AOTY

Neoadjuvant Nivolumab and Ipilimumab in Resectable Stage III Melanoma | NEJM In phase 1–2 trials in patients with resectable, macroscopic stage III melanoma, neoadjuvant immunotherapy was more efficacious than adjuvant immunotherapy. In this phase 3 trial, we randomly assig...

Looking fwd to 2025 - #clinicaltrials to cure #cancer & #melanoma, & #immunotherapy. My 2024 highlights:
www.nejm.org/doi/abs/10.1...
www.nejm.org/doi/full/10....
www.annalsofoncology.org/article/S092...
ascopubs.org/doi/10.1200/...
ascopubs.org/doi/10.1200/...
www.nature.com/articles/s41...